Clinical Trial Update: Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing strontium-89 with external-beam radiation therapy in men with metastatic castration-resistant prostate cancer and painful bone me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Strontium-89 (strontium-89)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Metastatic Cancer, Prostate Cancer | Phase 3 | Status: COMPLETED